REPUBLIC OF THE PHILIPPINES
HOUSE OF REPRESENTATIVES,
Quezon City

SIXTEENTH CONGRESS
First Regular Session

House BillNo. _ 939 2

Introduced by MAGDALO Party List RepresentativesFranciscoAshley L. Acedillo-and Gary
C. Alejano

EXPLANATORY NOTE

Article XUIL Section 12 of the Constitution provides for the establishment and maintenance of an
effective food and drug regulatory system. It also emphasized the role of the State to undertake
appropriate health, manpower development, and research that works for the advantage of the
people.

With recent reports about the threats brought about by the products entering the country, it could
not be concealed that the Filipino consumers needs more protection from the government.

Laws in the United States deem a drug to be misbranded unless the labeling of such drug lists the
identity of the country of manufacture of each active ingredient and each inactive ingredient of
the drug, which is listed in descending order based on the percentage of the number of such
ingredient in the final dosage form manufactured in such countries.

A law that guards the citizens of our country from potential risks caused by medications from
other countries is a necessity. Labeling, for one, can provide information concerning possible
damage of imported medicines to consumers.

Intending to improve the labeling standards in view of protecting the health of Filipino citizens,
this bill intends to require country of origin labeling on prescription and over-the-counter drugs.

In view of the foregoing, the immediate approval of this bill is earnestly sought.

XN

ISCO ASHLEY L. ACEDILLO ARY C. KLEJANO.


REPUBLIC OF THE PHILIPPINES
HOUSE OF REPRESENTATIVES
Quezon City

SIXTEENTH CONGRESS
First Regular Session

House BillNo. _ 935

Introduced by MAGDALO Party List Representatives Francisco Ashley L. Acedillo and
Gary C. Alejano

AN ACT
TO REQUIRE COUNTRY OF ORIGIN LABELING ON PRESCRIPTION AND OVER-
THE-COUNTER DRUGS

Be it enacted by the Senate and House of Representatives of the Philippines in Congress
assembled:

SECTION 1. Short Title, — This Act shall be known as the “Transparency in Drug

Labeling Act”.

SEC. 2. Declaration of Policy. — It is hereby declared the policy of the State to endeavor

services that are responsive to the health needs and problems of all citizens in the country.

SEC. 3. Country of Origin Labeling for Drugs. ~ Labeling on prescription and over-the-

counter drugs shall be required of the following:

a) The identity of the manufacturing country of each active ingredient of the drug, listed
in descending order based on the percentage of the number of active ingredients in the

final dosage form manufactured in such countries.

b) The identity of the manufacturing country of each inactive ingredient of the drug,
listed in descending order based on the percentage of the number of inactive

ingredients in the final dosage form manufactured in such countries.


SEC. 4. Separability Clause. — If any provision of this Act shall at any time be found to
be unconstitutional or invalid, the remainder thereof not affected by such declaration shall

remain in full force and effect.

SEC. 5. Repealing Clause, ~ All laws, decrees, rules or regulations inconsistent with the

provisions of this Act are hereby repealed or modified accordingly.

SEC. 6. Effectivity Clause. ~ This Act shall take effect after fifteen (15) days following

its complete publication in two (2) newspapers of general circulation.

Approved,